Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-013553
Filing Date
2024-02-12
Accepted
2024-02-12 06:06:37
Documents
1
Group Members
DAVID ROSEN

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm245464d8_sc13ga.htm SC 13G/A 76521
  Complete submission text file 0001104659-24-013553.txt   78128
Mailing Address 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017
Business Address 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017 2124181881
Rubric Capital Management LP (Filed by) CIK: 0001687509 (see all company filings)

EIN.: 300934659 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472 617-952-0555
Werewolf Therapeutics, Inc. (Subject) CIK: 0001785530 (see all company filings)

EIN.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92515 | Film No.: 24617227
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)